Keeping the healthcare industry protected
In the early days of the COVID-19 pandemic, Cue sponsored a clinical study of the Cue COVID-19 Test at EvergreenHealth in the Greater Seattle Area.
01/04
Cue worked with EvergreenHealth in the Greater Seattle Area to develop a clinical study of Cue’s COVID-19 Test in their Emergency Room. The goal of the study was to evaluate the sensitivity and reliability of the test in a point-of-care facility.
Cue worked with EvergreenHealth in the Greater Seattle Area to develop a clinical study of Cue’s COVID-19 Test in their Emergency Room. The goal of the study was to evaluate the sensitivity and reliability of the test in a point-of-care facility.
Cue’s closed, automated system eliminates the risk of exposure for healthcare professionals, making it safe to administer to patients.
Cue’s COVID-19 Test is administered with a pain-free nasal swab used for sample collection from the lower portion of both nostrils, making it a more comfortable, less invasive experience for patients.
Cue’s COVID-19 Test is a portable, compact, highly sensitive, molecular test that delivers results to a mobile device in about 20 minutes. An ideal solution for frequent, fast, reliable, molecular testing at point-of-care.
“The combination of the safety profile and the speed of the result should make Cue a winner in the marketplace.”
Dr. Chad Crystal
President, EvergreenHealth Emergency Services
“The reality is, it’s such a simple test. It doesn’t require any medical knowledge or sophistication to know how to do it.”
Dr. Jack Handley
ER physician, EvergreenHealth
Research Director, EvergreenHealth Emergency Services
Solutions
One system, any industry
The Cue Integrated Care Platform delivers a fast, accurate, and scalable solution for organizations of every type and size, from business to healthcare to public sector, education, and more.
